RegulatoryOfficial
FDA publishes Q&A guidance on transferring a 510(k) clearance between holders
🇺🇸 FDA CBER · Thu 19 Nov 2026
The document addresses common questions on selling or transferring a 510(k), including when a new holder need not file a fresh submission and when the original submission number must be used.
The US Food and Drug Administration has published a question-and-answer guidance on the transfer or sale of a premarket notification (510(k)) clearance from one holder to another. The page is dated 19 November 2026 and filed under docket number FDA-2024-D-1528. It lists biologics and medical devices as regulated products, and names the Center for Devices and Radiological Health as the issuing office.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Article written by VigiEye from the official source (FDA CBER). AI-assisted; check the source before acting.
More Regulatory
All →
FDA extends review of Belite Bio's tinlarebant for Stargardt disease to May 2027
Belite Bio, Inc (BLTE) · Fri 20 Nov 2026
FDA publishes new and revised draft product-specific guidances on bioequivalence for generics
🇺🇸 FDA · Fri 20 Nov 2026
Dutch inspectorate posts Biotronik field safety notice on ICD and CRT-D lithium plating
🇳🇱 IGJ · Thu 19 Nov 2026
Allarity secures US patent on twice-daily stenoparib dosing, with protection expected into 2045
🇺🇸 Allarity Therapeutics, Inc. (ALLR) · Thu 19 Nov 2026
China approves HUTCHMED's Syk inhibitor SYVIK for chronic ITP and warm autoimmune haemolytic anaemia
HUTCHMED (China) Ltd (HCM) · Thu 19 Nov 2026
Scancell's melanoma DNA vaccine iSCIB1+ gets FDA RMAT designation ahead of Phase 3
Scancell Holdings plc · Thu 19 Nov 2026